Rankings
▼
Calendar
FOLD FY 2025 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$634M
+20.0% YoY
Gross Profit
$554M
87.3% margin
Operating Income
$34M
5.4% margin
Net Income
-$27M
-4.3% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$33M
Free Cash Flow
$30M
Stock-Based Comp.
$87M
Balance Sheet
Total Assets
$950M
Total Liabilities
$676M
Stockholders' Equity
$274M
Cash & Equivalents
$214M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$634M
$528M
+20.0%
Gross Profit
$554M
$475M
+16.5%
Operating Income
$34M
$25M
+38.7%
Net Income
-$27M
-$56M
+51.7%
← Q4 2024
All Quarters
Q1 2025 →